Jonas BA, DiNardo C, Fracchiolla N, Pristupa A, et al. Use of CYP3Ai and impact on outcomes in patients with AML treated with venetoclax plus azacitidine in the VIALE-A study. Am J Hematol 2022 Aug 28. doi: 10.1002/ajh.26707.
PMID: 36053878